Peer-influenced content. Sources you trust. No registration required. This is HCN.

Journal of Clinical OncologyModern Myeloma Therapy + Sustained Minimal Residual Disease–Negative = (Functional) Cure!

The future certainly looks bright for patients diagnosed with multiple myeloma, as this opinion piece points out, thanks to combination therapies partnered with easily available, reliable minimal residual disease (MRD) assays. How close are we to a functional cure?

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form